Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

4.130 +0.020 (+0.49%)
Official Closing Price Updated: 4:15 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,193,341
Open 4.120
Bid (Size) 3.820 (20)
Ask (Size) 4.100 (4)
Prev. Close 4.110
Today's Range 4.060 - 4.180
52wk Range 3.812 - 29.30
Shares Outstanding 92,200,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
Correction: Time of BofA Conference 
From Myriad Genetics, Inc.
Via GlobeNewswire
3 of Wall Street’s Favorite Stocks in Dangerous Territory
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory

Performance

YTD
-69.4%
-69.4%
1 Month
-47.8%
-47.8%
3 Month
-71.6%
-71.6%
6 Month
-72.9%
-72.9%
1 Year
-83.2%
-83.2%

More News

Read More
Securities Fraud Investigation Into Myriad Genetics, Inc. (MYGN) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
Earnings Scheduled For May 6, 2025
Via Benzinga
Myriad Genetics's Earnings: A Preview
Via Benzinga
Myriad Genetics, Inc. (MYGN) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
Myriad Genetics Shares Tank 41% On Analyst Downgrades, Weaker Guidance: Yet Retail Investors Remain Bullish
Via Stocktwits
Securities Fraud Investigation Into Myriad Genetics, Inc. (MYGN) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
What Analysts Are Saying About Myriad Genetics Stock
Via Benzinga
Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology
From Myriad Genetics, Inc.
Via GlobeNewswire
Top movers in Wednesday's session
Via Chartmill
Why Myriad Genetics (MYGN) Stock Is Down Today
Via StockStory
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Falls 1%; Uber Sales Miss Estimates
Via Benzinga
Topics Earnings
Exposures Financial Fossil Fuels
Wednesday's session: top gainers and losers
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
These stocks that are showing activity before the opening bell on Wednesday.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Myriad Genetics (NASDAQ:MYGN) Misses Q1 Sales Targets, Stock Drops 14.5%
Via StockStory
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Which stocks are moving after the closing bell on Tuesday?
Via Chartmill
Myriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance
From Myriad Genetics, Inc.
Via GlobeNewswire
What To Expect From Myriad Genetics’s (MYGN) Q1 Earnings
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Unprofitable Stocks Walking a Fine Line
Via StockStory
1 Unprofitable Stock to Target This Week and 2 to Be Wary Of
Via StockStory

Frequently Asked Questions

Is Myriad Genetics, Inc. - Common Stock publicly traded?
Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
What exchange does Myriad Genetics, Inc. - Common Stock trade on?
Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
What is the current price of Myriad Genetics, Inc. - Common Stock?
The current price of Myriad Genetics, Inc. - Common Stock is 4.130
When was Myriad Genetics, Inc. - Common Stock last traded?
The last trade of Myriad Genetics, Inc. - Common Stock was at 05/16/25 04:15 PM ET
What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
The market capitalization of Myriad Genetics, Inc. - Common Stock is 380.79M
How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
Myriad Genetics, Inc. - Common Stock has 381M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.